# An Open Label Study of CM-AT for the Treatment of Children With Autism

> **NCT02649959** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Curemark** · enrollment: 405 (estimated)

## Conditions studied

- Autism

## Interventions

- **DRUG:** CM-AT

## Key facts

- **NCT ID:** NCT02649959
- **Lead sponsor:** Curemark
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-10
- **Primary completion:** 2028-01
- **Final completion:** 2028-01
- **Target enrollment:** 405 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02649959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02649959, "An Open Label Study of CM-AT for the Treatment of Children With Autism". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02649959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*